TTK Healthcare [TTKHLTCARE] vs Cipla [CIPLA] Detailed Stock Comparison
TTK Healthcare
NSE
Loading...
Cipla
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: TTK Healthcare wins in 5 metrics, Cipla wins in 15 metrics, with 0 ties. Cipla appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | TTK Healthcare | Cipla | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.50 | 23.65 | Cipla |
| Price-to-Book Ratio | 1.51 | 4.08 | TTK Healthcare |
| Debt-to-Equity Ratio | 2.27 | 1.40 | Cipla |
| PEG Ratio | -0.43 | 2.31 | TTK Healthcare |
| EV/EBITDA | 27.35 | 16.57 | Cipla |
| Profit Margin (TTM) | 7.69% | 19.62% | Cipla |
| Operating Margin (TTM) | 0.22% | 22.31% | Cipla |
| EBITDA Margin (TTM) | 0.22% | 22.31% | Cipla |
| Return on Equity | 7.67% | 16.85% | Cipla |
| Return on Assets (TTM) | 6.37% | 14.10% | Cipla |
| Free Cash Flow (TTM) | $-168.16M | $34.57B | Cipla |
| Dividend Yield | 0.74% | 1.72% | Cipla |
| 1-Year Return | -26.30% | 9.78% | Cipla |
| Price-to-Sales Ratio (TTM) | 1.96 | 4.63 | TTK Healthcare |
| Enterprise Value | $7.83B | $1,175.27B | Cipla |
| EV/Revenue Ratio | 0.96 | 4.28 | TTK Healthcare |
| Gross Profit Margin (TTM) | 55.03% | 68.25% | Cipla |
| Revenue per Share (TTM) | $580 | $340 | TTK Healthcare |
| Earnings per Share (Diluted) | $44.67 | $66.67 | Cipla |
| Beta (Stock Volatility) | 0.30 | 0.10 | Cipla |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
TTK Healthcare vs Cipla Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| TTK Healthcare | -0.93% | 2.45% | -7.93% | -5.97% | 0.26% | -16.54% |
| Cipla | 0.42% | -0.78% | 0.53% | 7.61% | 12.28% | 6.82% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| TTK Healthcare | -26.30% | 33.01% | 151.57% | 47.76% | 204.17% | 312.27% |
| Cipla | 9.78% | 55.60% | 118.09% | 143.29% | 414.67% | 1,037.40% |
Performance & Financial Health Analysis: TTK Healthcare vs Cipla
| Metric | TTKHLTCARE | CIPLA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹16.09B | ₹1.27T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 3,602 | 1,582,887 |
| 90 Day Avg. Volume | 4,442 | 1,653,799 |
| Last Close | ₹1,158.50 | ₹1,587.00 |
| 52 Week Range | ₹1,101.05 - ₹1,893.95 | ₹1,335.00 - ₹1,607.80 |
| % from 52W High | -38.83% | -1.29% |
| All-Time High | ₹1,893.95 (Sep 09, 2024) | ₹1,607.80 (Aug 25, 2025) |
| % from All-Time High | -38.83% | -1.29% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.03% |
| Quarterly Earnings Growth | -0.59% | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.20% |
| Operating Margin (TTM) | 0.00% | 0.22% |
| Return on Equity (TTM) | 0.08% | 0.17% |
| Debt to Equity (MRQ) | 2.27 | 1.40 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹753.73 | ₹386.24 |
| Cash per Share (MRQ) | ₹605.17 | ₹131.44 |
| Operating Cash Flow (TTM) | ₹338.96M | ₹55.16B |
| Levered Free Cash Flow (TTM) | ₹816.57M | ₹52.73B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.74% | 1.72% |
| Last 12-Month Dividend | ₹10.00 | ₹26.00 |
Valuation & Enterprise Metrics Analysis: TTK Healthcare vs Cipla
| Metric | TTKHLTCARE | CIPLA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.50 | 23.65 |
| Forward P/E | N/A | 24.81 |
| PEG Ratio | -0.43 | 2.31 |
| Price to Sales (TTM) | 1.96 | 4.63 |
| Price to Book (MRQ) | 1.51 | 4.08 |
| Market Capitalization | ||
| Market Capitalization | ₹16.09B | ₹1.27T |
| Enterprise Value | ₹7.83B | ₹1.18T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.96 | 4.28 |
| Enterprise to EBITDA | 27.35 | 16.57 |
| Risk & Other Metrics | ||
| Beta | 0.30 | 0.10 |
| Book Value per Share (MRQ) | ₹753.73 | ₹386.24 |
Financial Statements Comparison: TTK Healthcare vs Cipla
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TTKHLTCARE | CIPLA |
|---|---|---|
| Revenue/Sales | ₹2.26B | ₹68.37B |
| Cost of Goods Sold | ₹1.02B | ₹21.71B |
| Gross Profit | ₹1.25B | ₹46.66B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹4.88M | ₹15.25B |
| EBITDA | ₹206.11M | ₹20.37B |
| Pre-Tax Income | ₹176.54M | ₹17.70B |
| Income Tax | ₹46.54M | ₹4.78B |
| Net Income (Profit) | ₹129.99M | ₹12.92B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TTKHLTCARE | CIPLA |
|---|---|---|
| Cash & Equivalents | ₹90.06M | ₹5.89B |
| Total Current Assets | ₹11.04B | ₹232.89B |
| Total Current Liabilities | ₹2.11B | ₹54.84B |
| Long-Term Debt | ₹17.73M | ₹2.52B |
| Total Shareholders Equity | ₹10.65B | ₹312.89B |
| Retained Earnings | ₹9.40B | ₹256.44B |
| Property, Plant & Equipment | ₹808.99M | ₹52.62B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TTKHLTCARE | CIPLA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TTKHLTCARE | CIPLA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 3,602 | 1,582,887 |
| Average Daily Volume (90 Day) | 4,442 | 1,653,799 |
| Shares Outstanding | 14.13M | 807.62M |
| Float Shares | 3.27M | 562.88M |
| % Held by Insiders | 0.77% | 0.31% |
| % Held by Institutions | 0.03% | 0.40% |
Dividend Analysis & Yield Comparison: TTK Healthcare vs Cipla
| Metric | TTKHLTCARE | CIPLA |
|---|---|---|
| Last 12-Month Dividend | ₹10.00 | ₹26.00 |
| Last 12-Month Dividend Yield | 0.74% | 1.72% |
| 3-Year Avg Annual Dividend | ₹13.33 | ₹16.00 |
| 3-Year Avg Dividend Yield | 0.85% | 0.76% |
| 3-Year Total Dividends | ₹40.00 | ₹48.00 |
| Ex-Dividend Date | Jul 18, 2025 | Jun 27, 2025 |